Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 3 Interventional

Ursodiol-Methotrexate for Primary Biliary Cirrhosis

ClinicalTrials.gov ID: NCT00006168

Public ClinicalTrials.gov record NCT00006168. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Jul 21, 2026, 4:03 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Study identification

NCT ID
NCT00006168
Recruitment status
Completed
Study type
Interventional
Phase
Phase 3
Lead sponsor
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
NIH
Enrollment
Not listed

Conditions and interventions

Interventions

  • Methotrexate Drug

Drug

Eligibility (public fields only)

Age range
20 Years to 69 Years
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Dec 31, 1993
Primary completion
Not listed
Completion
Feb 29, 2004
Last update posted
Jan 12, 2010

1994 – 2004

United States locations

U.S. sites
12
U.S. states
11
U.S. cities
12
Facility City State ZIP Site status
Keck School of Medicine at U.S.C. Los Angeles California 90033
U California Medical Center San Francisco California 94143
Yale University School of Medicine New Haven Connecticut 06520-8019
Emory University School of Medicine Atlanta Georgia 30322
Saint Louis University St Louis Missouri 63104
University of Nebraska Medical Center Omaha Nebraska 68198-3285
Cleveland Clinic Cleveland Ohio 44195
Oregon Health Sciences University Portland Oregon 97201
Albert Einstein Medical Center Philadelphia Pennsylvania 19141
UT Southwestern Medical Center at Dallas Dallas Texas 75235-9151
Medical College of Virginia Richmond Virginia 23298-0711
University of Washington Medical Center Seattle Washington 98195

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT00006168, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Jan 12, 2010 · Synced Jul 21, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT00006168 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →